The return to a ‘new normal’ post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare but also generate practice revenue, which is vital for economic recovery. The Profender® and Drontal® range come with a strong heritage and reputation and so form a central part of these discussions.
Caitrina Oakes, Vetoquinol Managing Director UK and Ireland, says she is delighted to have brought the brands into the Vetoquinol portfolio and believes they are a natural fit for the company. “Vetoquinol has long held a reputation for delivering therapeutic products that extend the capability of clinicians to treat and manage disease. Preventative care is also playing an increasingly central role in practices, with the emphasis on helping pets live longer, healthier, happier lives. With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender® and Drontal® highly relevant in the current environment.”
She continues, “It’s a very challenging time for many veterinary practices as everyone adapts to the post-COVID world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender® and Drontal® to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”
Profender® is a single-dose, prescription-only spot-on solution against roundworm and tapeworm for cats and holds the prestigious Easy-to-give Award from the International Society of Feline Medicine.
The Drontal® range encompasses a portfolio of single-dose anthelmintic products for cats and dogs. This includes the Drontal® Tasty Bone range, which comes in the form of palatable, bone-shaped tablets for dogs, as well as the Drontal® Cat, Drontal® Puppy, Dronspot® and Droncit® product ranges.
Up to date information on the brands and their distribution can be found on this website, by calling 01280 814500, or practices can contact their Vetoquinol Territory Manager directly.
Drontal Dog Tasty Bone/Bone XL Tablets contain febantel, praziquantel and pyrantel. NFA-VPS (UK) CAM (ROI). Drontal Cat/Cat XL Tablets contain praziquantel and pyrantel embonate. NFA-VPS (UK) CAM (ROI). Droncit Tablets and Spot On contain praziquantel. AVM-GSL (UK). Droncit Tablets contain praziquantel. CAM (ROI). Drontal Oral Suspension for Puppies contains febantel and pyrantel. NFA-VPS (UK) CAM (ROI). Dronspot contains emodepside and praziquantel. NFA-VPS (UK). Profender contains emodepside and praziquantel. POM-V (UK) POM (ROI). Further information is available from Vetoquinol (www.vetoquinol.co.uk). Datasheets are available on the NOAH (UK) and APHA (IE) websites (www.noahcompendium.co.uk / www.apha.ie/AnimalHealth/VeterinaryCompendium). Alternatively, a full copy of the SPC can be found on the VMD (UK) or HPRA (IE) websites (www.vmd.defra.gov.uk/ProductInformationDatabase/Default.aspx / www.hpra.ie/homepage/veterinary).
Latest news of vetoquinol
05 May 2021Veterinary pharmaceuticals company, Vetoquinol UK, is evaluating their environmental impact and assessing areas for...
08 Apr 2021Veterinary practices can benefit from funding to install a new software that makes it simpler to report antibiotic usage on...